Back
Phathom Pharmaceuticals Stock Price Chart
Sponsored
PHAT
Sponsored
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
23
PHAT
Phathom Pharmaceuticals
Last Price:
$8.10
Seasonality Move:
-9.47%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Phathom Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.87 | Buy |
20-day SMA: | 8.37 | Sell |
50-day SMA: | 11.77 | Sell |
200-day SMA: | 12.08 | Sell |
8-day EMA: | 7.9 | Buy |
20-day EMA: | 8.6 | Sell |
50-day EMA: | 10.75 | Sell |
200-day EMA: | 12.02 | Sell |
Phathom Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.02 | Sell |
Relative Strength Index (14 RSI): | 39 | Sell |
Chaikin Money Flow: | 605516 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.93 - 9.11) | Sell |
Bollinger Bands (100): | (9.81 - 17.69) | Sell |
Phathom Pharmaceuticals Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 8.10 while PHAT 8-day simple moving average is 7.87, which is a Buy signal.
-
The stock price of PHAT is 8.10 while Phathom Pharmaceuticals 20-day SMA is 8.37, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day simple moving average is 11.77 while PHAT share price is 8.10, making it a Sell technically.
-
PHAT stock price is 8.10 and Phathom Pharmaceuticals 200-day simple moving average is 12.08, creating a Sell signal.
PHAT Technical Analysis vs Fundamental Analysis
Sell
23
Phathom Pharmaceuticals (PHAT)
is a Sell
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a SellThe current Phathom Pharmaceuticals [PHAT] share price is $8.10. The Score for PHAT is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
553.9M
Price in USD:
8.10
Share Volume:
1.1M
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.71
52-Week Low:
6.07
Sell
23
Phathom Pharmaceuticals (PHAT)
is a Sell
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?The Phathom Pharmaceuticals stock price is 8.10 USD today.
-
Will PHAT stock go up or go down?Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Phathom Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 8.10 while PHAT 8-day exponential moving average is 7.90, which is a Buy signal.
-
The stock price of PHAT is 8.10 while Phathom Pharmaceuticals 20-day EMA is 8.60, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day exponential moving average is 10.75 while PHAT share price is 8.10, making it a Sell technically.
-
PHAT stock price is 8.10 and Phathom Pharmaceuticals 200-day simple moving average is 12.02, creating a Sell signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and an increase next year of $1.13 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
-
PHAT Moving Average Covergence Divergence (MACD) indicator is -1.02, suggesting Phathom Pharmaceuticals is a Sell
-
Phathom Pharmaceuticals Relative Strength Index (RSI) is 39, which suggest Phathom Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Phathom Pharmaceuticals is (7.93 - 9.11), which suggest Phathom Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Phathom Pharmaceuticals is (9.81 - 17.69), which suggest Phathom Pharmaceuticals is a Sell
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.